Loading...
IFNL1
The complexes of interferon-λ with an antibody or antigen-binding antibody fragment are more efficacious for treatment of cancer, asthma, Alzheimer's disease, multiple sclerosis or viral infection than interferon-λ alone, antibody alone, or the combination of unconjugated interferon-λ and antibody.
Predicted location
Secreted
Single cell type specificity
Cell type enhanced (NK-cells, Langerhans cells, T-cells, dendritic cells)
Immune cell specificity
Group enriched (NK-cell, MAIT T-cell, memory CD8 T-cell, gdT-cell, myeloid DC, naive CD8 T-cell, memory CD4 T-cell)
Cell line specificity
Not detected
Molecular function
Cytokine
More Types Infomation
- Mouse Anti-IFNL1 Recombinant Antibody (clone CBL597) (NEUT-1050CQ)
-
- Species Reactivity: Human
- Type: Mouse IgG2a
- Application: ELISA, Neut
- Mouse Anti-IFNL1 Recombinant Antibody (clone CBL103) (NEUT-1049CQ)
-
- Species Reactivity: Human
- Type: Mouse IgG2
- Application: Neut, WB
- Mouse Anti-IFNL1 Recombinant Antibody (clone 10X23) (NEUT-1047CQ)
-
- Species Reactivity: Human
- Type: Mouse IgG2
- Application: Neut
- Human Anti-IFNL1 Antibody, mRNA (TAB-381CL-mRNA)
-
- Species Reactivity: Human
-
- Species Reactivity: Human
- Type: ADCC enhanced antibody
- Anti-Human IFNL1 Recombinant Antibody (TAB-381CL)
-
- Species Reactivity: Human
- Type: Antibody
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
For Research Use Only. Not For Clinical Use.